A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens
International Journal of Molecular Sciences · 23.06.2026 · 27 (13) · 5660
DOI: 10.3390/ijms27135660 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.06.2026. Verfasst von Henghui Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, HLA-DR4 Antigen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Major Program of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Post-translational modification (PTM) neoantigens have emerged as key drivers of autoimmune inflammation. However, standardized protocols for MHC Class II tetramer preparation for the detection of such antigen-specific T cells remain limited, hindering the broader application of this important discovery. This study systematically engineered an HLA-DR4 (HLA-DRB1*04:02 and HLA-DRA*01:01) tetramer platform based on carboxyethyl-modified neoantigen ITGA2B peptide (ITG-CE), a PTM associated with autoimmune diseases (AUIDs) such as Ankylosing Spondylitis (AS). The platform provides a major histocompatibility complex (MHC) Class II tetramer associated with the PTM neoantigen and integrates modular protein construct, a controllable PTM peptide exchange strategy, and a specific T cell receptor (TCR) validation model. It can be employed to investigate PTM neoantigen presentation and CD4+ T cell auto-reactivity, providing extensive application value for future research into the mechanisms of PTM-induced AUIDs and immune monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Shanghai University, Shanghai 200444, China.
ORCID-Profile: Henghui Li, Hongyan Ma
Förderung
- the National Key Research and Development Program of China
- the National Natural Science Foundation of China
- the Major Program of the National Natural Science Foundation of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Major Program of the National Natural Science Foundation of China
Zitieren
APA
Li, H., Li, J., Wang, Y., Ma, H., Tang, F., & Chen, L. (2026). A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens. International Journal of Molecular Sciences, 27(13), 5660. https://doi.org/10.3390/ijms27135660
Vancouver
Li H, Li J, Wang Y, Ma H, Tang F, Chen L. A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens. International Journal of Molecular Sciences. 2026;27(13):5660. doi:10.3390/ijms27135660
BibTeX
@article{Li2026,
author = {Li, Henghui and Li, Jingyao and Wang, Ying and Ma, Hongyan and Tang, Fen and Chen, Liang},
title = {A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5660},
doi = {10.3390/ijms27135660}
}
EUVIMED